Details for New Drug Application (NDA): 213936
✉ Email this page to a colleague
The generic ingredient in METHYLPHENIDATE HYDROCHLORIDE is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
Summary for 213936
Tradename: | METHYLPHENIDATE HYDROCHLORIDE |
Applicant: | Accord Hlthcare |
Ingredient: | methylphenidate hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 213936
Physiological Effect | Central Nervous System Stimulation |
Suppliers and Packaging for NDA: 213936
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET;ORAL | 213936 | ANDA | Accord Healthcare, Inc. | 16729-478 | 16729-478-01 | 100 TABLET in 1 BOTTLE (16729-478-01) |
METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET;ORAL | 213936 | ANDA | Accord Healthcare, Inc. | 16729-479 | 16729-479-01 | 100 TABLET in 1 BOTTLE (16729-479-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Oct 28, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Oct 28, 2020 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Oct 28, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription